Featured
Stalemate over PBS pricing
Health Minister Mark Butler says this “revolutionary class of drugs” must be subsidised “at some point” but negotiations over pricing have clearly hit a brick wall
Leadership & People
Ah, so that's where he's gone...
Australian leader unveils his next career move after announcing his departure from a top US-based role at J&J a fortnight ago
Regulatory & Reimbursement
GBMA calls for supply chain overhaul
Peak body for Australia’s generic and biosimilar medicines industry looks to shift the focus from reacting to shortages to preventing them before they occur in a new White Paper
Leadership & People
New Aussie Country Head tapped
A meteoric rise to the top for this former MD who has gone from Franchise Head to Country Head in just 10 months
Jobs
Regulatory & Reimbursement
Novartis expands two franchises
The Swiss pharma giant has expanded its offerings in haematology and ophthalmology
Latest
Doctors turn up the heat on pharma
Pharma's not alone in feeling frustration over timely access to medicines, doctors feel the pain too and want industry to fix it
Jobs & Workplace
Great workplace, six years running
CEO of the Australian business says the achievement belongs to the people who bring the company's values to life
Latest
Company announces fresh layoffs
A cost-saving program that started in 2023 has been extended again bringing more job cuts plus the other popular stories this week
Featured
21 Aussie Country Leaders exit in a year
There has been a seismic shift in Country Leadership in Australia with 21 ANZ bosses departing in just 12 months
Regulation & Legal
$170M franchise safe for another year
Injunction prevents four drugs from facing first generic price cuts for at least another 12 months
Leadership & People
Ex-J&J boss lands 5th Country Leader job
Seasoned industry executive takes top job in expanding business with a growing portfolio of essential medicines
Jobs & Workplace
Pharma flags more job cuts
Ongoing 'cost realignment' has been extended with more global redundancies but the impact on the local team is unknown
- Regulatory & Reimbursement New rival ready to crash CAR-T market
- Regulatory & Reimbursement Diabetes drug restrictions dropped
- Regulatory & Reimbursement Aussie peanut drug on FDA fast track
- Other News Pharma exec up for Patient Choice gong
- Regulatory & Reimbursement The pharmacy of unavailable drugs
- Other News Who's moved to global HQ?
- Regulatory & Reimbursement Backlash over PBAC monitoring
- Jobs & Workplace Who's jumped ship to be first CMO?
- Other News Deal paves way for global rollout
- Industry & Companies Med affairs, the time is now
- Other News Brown nosing allowed, court rules
- Other News Where will this exec land next?
